Bristol Myers Squibb to build new cell therapy manufacturing site in the Netherlands
Bristol Myers Squibb to build new cell therapy manufacturing site in the Netherlands Bristol Myers Squibb (BMS) will build a new cell therapy manufacturing site in Leiden, the Netherlands: marking the company’s first cell therapy manufacturing facility in Europe and its fifth globally. BMS is building up its cell manufacturing footprint and network across the globe. The American pharmaceutical company currently has cell therapy manufacturing facilities in the US: including in Bothwell, WA and Summit, NJ. Last month BMS announced the addition of a new facility in...
Source: biopharma-reporter.com